Kathy Giusti, M.B.A. ’85, founder and CEO of the Multiple Myeloma Research Foundation (MMRF), will address this year's imminent graduates of Harvard Business School as Class Day speaker. She founded the MMRF in 1998 after being diagnosed with multiple myeloma. This spring, Time magazine named her one of the "100 most influential people" in the world. Multiple myeloma is a cancer of plasma cells—white blood cells that produce antibodies; it affects from one to four people per 100,000 and constitutes 1 percent of all cancers. Before starting MMRF, Giusti was an executive with pharmaceutical companies, and she has sought to encourage the development of drugs to treat the disease using a business model, rather than an academic model, of drug development. The MMRF is the world's top funder of myeloma research: it has raised more than $165 million to fund research.
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
Multiple myeloma research crusader Kathy Giusti to speak at HBS Class Day
The founder of the Multiple Myeloma Research Foundation will speak at Harvard Business School Class Day.
You might also like
A History of Harvard Magazine
Harvard’s independent alumni magazine—at 127 years old
Harvard Announces Four University Professors
Catherine Dulac, Noah Feldman, Claudia Goldin, and Cumrun Vafa receive the University’s highest faculty distinction.
Creepy Crawlies and Sticky Murder Weapons at Harvard
In the shadows of Singapore’s forests, an ancient predator lies in wait—the velvet worm.
Most popular
Explore More From Current Issue
Rachel Ruysch’s Lush (Still) Life
Now on display at the Museum of Fine Arts, a Dutch painter’s art proved a treasure trove for scientists.
A Flu Vaccine That Actually Works
Next-gen vaccines delivered directly to the site of infection are far more effective than existing shots.